DE3875611T2 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number
DE3875611T2
DE3875611T2 DE8888907737T DE3875611T DE3875611T2 DE 3875611 T2 DE3875611 T2 DE 3875611T2 DE 8888907737 T DE8888907737 T DE 8888907737T DE 3875611 T DE3875611 T DE 3875611T DE 3875611 T2 DE3875611 T2 DE 3875611T2
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
idazoxan
carbidopa
alpha
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888907737T
Other languages
English (en)
Other versions
DE3875611D1 (de
Inventor
Saad Al-Damluji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Publication of DE3875611D1 publication Critical patent/DE3875611D1/de
Application granted granted Critical
Publication of DE3875611T2 publication Critical patent/DE3875611T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8888907737T 1987-09-02 1988-09-01 Pharmazeutische zusammensetzungen. Expired - Fee Related DE3875611T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878720600A GB8720600D0 (en) 1987-09-02 1987-09-02 Pharmaceutical compositions
PCT/GB1988/000717 WO1989001774A1 (en) 1987-09-02 1988-09-01 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE3875611D1 DE3875611D1 (de) 1992-12-03
DE3875611T2 true DE3875611T2 (de) 1993-03-11

Family

ID=10623138

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888907737T Expired - Fee Related DE3875611T2 (de) 1987-09-02 1988-09-01 Pharmazeutische zusammensetzungen.

Country Status (8)

Country Link
US (1) US5015654A (de)
EP (1) EP0345304B1 (de)
JP (1) JPH02500596A (de)
AT (1) ATE81775T1 (de)
DE (1) DE3875611T2 (de)
DK (1) DK211489D0 (de)
GB (2) GB8720600D0 (de)
WO (1) WO1989001774A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109007A (en) * 1989-01-06 1992-04-28 The United States Of America As Represented By The Department Of Health And Human Services Attenuation of ethyl alcohol intoxication with alpha-2 adrenoceptor antagonists
SE9203594D0 (sv) * 1992-11-30 1992-11-30 Christer Nystroem Laekemedel i dispersa system
US5492907A (en) * 1992-12-09 1996-02-20 The United States Of America As Represented By The Department Of Health & Human Services Antipsychotic composition and method of treatment
US5663167A (en) * 1992-12-09 1997-09-02 The United States Of America As Represented By The Department Of Health And Human Services Antipsychotic composition and method of treatment
FR2759291A1 (fr) * 1997-02-13 1998-08-14 Pf Medicament Produit contenant de l'idazoxan et de la 1-dopa comme preparation pharmaceutique combinee utilise pour la maladie de parkinson
WO2005025561A1 (en) * 2003-09-04 2005-03-24 Synergia Pharma, Inc. Compositions and methods for orthostatic intolerance
EP2363123A1 (de) * 2006-06-28 2011-09-07 Chelsea Therapeutics, Inc. Pharmazeutische Zusammensetzungen enthaltend Droxidopa
MX2009009624A (es) * 2007-03-09 2009-12-11 Chelsea Therapeutics Inc Droxidopa y composicion farmaceutica de la misma para el tratamiento de la fibromialgia.
EP2142185B1 (de) * 2007-03-12 2012-08-15 Chelsea Therapeutics, Inc. Droxidopa und pharmazeutische zusammensetzung davon zur behandlung von neural vermittelter hypertonie
NZ581707A (en) * 2007-05-07 2011-05-27 Chelsea Therapeutics Inc Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
US4673689A (en) * 1985-09-25 1987-06-16 Massachusetts Institute Of Technology Method and composition for enhancing the effect of indirect-acting sympathomimetic amines

Also Published As

Publication number Publication date
GB8720600D0 (en) 1987-10-07
ATE81775T1 (de) 1992-11-15
DE3875611D1 (de) 1992-12-03
GB2209281B (en) 1991-08-21
DK211489A (da) 1989-05-01
GB8820654D0 (en) 1988-10-05
US5015654A (en) 1991-05-14
WO1989001774A1 (en) 1989-03-09
JPH02500596A (ja) 1990-03-01
DK211489D0 (da) 1989-05-01
EP0345304B1 (de) 1992-10-28
GB2209281A (en) 1989-05-10
EP0345304A1 (de) 1989-12-13

Similar Documents

Publication Publication Date Title
ITRM920155A1 (it) Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil1h-indol-5-metansolfonammide, relativo procedimento di preparazione e impiego della stessa nel trattamento di mammiferi
ES8505519A1 (es) Un procedimiento para la preparacion de 14-fluoromorfinanos utiles como analgesicos, narcoticos y-o agentes anorexicos.
KR870005637A (ko) 약물 데포
ATE198835T1 (de) Knochenwachstumsfördernde zusammensetzung
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
RU93004970A (ru) Производные циклоалкилзамещенного глутарамида, их применение, фармацевтическая композиция
SE8804629D0 (sv) New therapeutically active compounds
PT948527E (pt) Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
DK261490D0 (da) New pharmaceutical compound
DK581889A (da) Antiatherosclerotiske diarylforbindelser
DE3875611D1 (de) Pharmazeutische zusammensetzungen.
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
SE8204288D0 (sv) Apap-anticidum-komposition
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
ATE74505T1 (de) Schmerzpraeparat.
KR880009652A (ko) 3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물
ES2116452T3 (es) Composiciones farmaceuticas que comprenden agonistas de receptores 5ht1 y potenciadores de la absorcion.
IT1271398B (it) Composizioni farmaceutiche contenenti derivati polipeptidici del ferro per la terapia marziale

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee